Mammalian pluripotent stem cells, methods for their production, and uses thereof

Patent metadata

Field	Value
Publication number	US-10787658-B2
Application number	US-201916375006-A
Country	US
Kind code	B2
Filing date	Apr 4, 2019
Priority date	Aug 4, 2014
Publication date	Sep 29, 2020
Grant date	Sep 29, 2020

Abstract

The disclosure relates to nerve derived adult pluripotent stem cells characterized by expression of Oct4, Sox2, c-Myc, and Klf4, methods for obtaining them, and their use.

First claim

What is claimed is:

1. A method of producing a population of mammalian nerve derived adult pluripotent stem cells expressing Oct4, Sox2, c-Myc and Klf4 from a non-embryonic peripheral nerve from a subject, said method comprising:
providing a non-embryonic peripheral nerve exposed to NEDAPS cell proliferation conditions ex vivo or in vivo, wherein said non-embryonic peripheral nerve exposed to NEDAPS cell proliferation conditions comprises nerve derived adult pluripotent stem cells,
culturing ex vivo said non-embryonic peripheral nerve or said nerve derived adult pluripotent stem cells from said non-embryonic peripheral nerve, and
isolating cells expressing Oct4, Sox2, c-Myc, and KIf4 from culture to yield said population of mammalian nerve derived adult pluripotent stem cells,
wherein said NEDAPS cell proliferation conditions comprise exposure of said non-embryonic peripheral nerve to a neuroinflammatory agent, trauma, or a combination thereof,
wherein the neuroinflammatory agent is BMP2, tumor necrosis factor alpha, lnterleukin-1 Beta, nerve growth factor, histamine, Interleukin 6, or a combination thereof, and
wherein the trauma is a mechanical trauma, an electrical stimulation, an ultrasonic shock wave, a thermal insult, or a combination thereof.

2. The method of claim 1 , wherein the providing step comprises harvesting the non-embryonic peripheral nerve from the subject and exposing the non-embryonic peripheral nerve to the NEDAPS cell proliferation conditions ex vivo to yield said non-embryonic peripheral nerve comprising said nerve derived adult pluripotent stem cells.

3. The method of claim 1 , wherein when the peripheral nerve is exposed to said NEDAPS cell proliferation conditions in said subject in vivo, said method further comprising harvesting the peripheral nerve prior to said culturing.

4. The method of claim 3 , wherein the providing step comprises exposing the peripheral nerve to the NEDAPS cell proliferation conditions in vivo prior to the harvesting.

5. The method of claim 1 , wherein the trauma is a mechanical trauma which comprises compressing the peripheral nerve, cutting the peripheral nerve, mincing the peripheral nerve, or a combination thereof.

6. The method of claim 1 , wherein the peripheral nerve is disrupted prior to said culturing to release said nerve derived adult pluripotent stem cells from said peripheral nerve.

7. The method of claim 6 , wherein the peripheral nerve is disrupted by treatment with a protease.

8. The method of claim 1 , wherein the peripheral nerve is a sural nerve, a branch of a sural nerve, a proper digital nerve of a finger or toe, a gracilis branch of an obturator nerve, a segment of a medial antebrachial cutaneous nerve, a lateral antebrachial cutaneous nerve, a proximal third webspace fascicle nerve, or a posterior intraosseous nerve.

9. The method of claim 1 , wherein the culturing comprises culturing the peripheral nerve or nerve derived adult pluripotent stem cells from the peripheral nerve in a non-differentiating medium.

10. A method of producing a population of differentiated cells, comprising exposing a population of mammalian nerve derived adult pluripotent stem cells produced by the method of claim 1 to differentiation conditions.

11. The method of claim 10 , wherein the differentiated cells are mesoderm cells and the differentiation conditions comprise culturing the population in a mesoderm differentiation medium.

12. The method of claim 10 , wherein the differentiated cells are endoderm cells and the differentiation conditions comprise culturing the population in an endoderm differentiation medium.

13. The method of claim 10 , wherein the differentiated cells are ectoderm cells and the differentiation conditions comprise culturing the population in an ectoderm differentiation medium.

14. The method of claim 1 , wherein said step of culturing comprises culturing said peripheral nerve, wherein the peripheral nerve is disrupted after said culturing to release said nerve derived adult pluripotent stem cells from said peripheral nerve prior to said isolating.

15. The method of claim 14 , wherein the peripheral nerve is cultured in non-differentiating medium.

16. The method of claim 2 , wherein said NEDAPS cell proliferation conditions comprise exposing said non-embryonic peripheral nerve to trauma, wherein said nerve derived adult pluripotent stem cells released from said peripheral nerve are further cultured in medium comprising BMP2 prior to said isolating.

17. The method of claim 2 , wherein the non-embryonic peripheral nerve is exposed to the NEDAPS cell proliferation conditions in non-differentiating medium.

Assignees

• Univ Kansas

Inventors

• Heggeness Michael H

Classifications

• C12N5/0623 Primary

  Stem cells · CPC title

• C12N2506/08

  from cells of the nervous system · CPC title

• C12N13/00 Primary

  Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title

• C12N2501/155

  Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor · CPC title

• C12N5/0607

  Non-embryonic pluripotent stem cells, e.g. MASC (induced pluripotent stem cells C12N5/0696) · CPC title